Evaluation of marrow and blood haemopoietic progenitors in chronic lymphocytic leukaemia before and after chemotherapy
- 24 April 2009
- journal article
- Published by Wiley in European Journal of Haematology
- Vol. 61 (1) , 14-20
- https://doi.org/10.1111/j.1600-0609.1998.tb01055.x
Abstract
No abstract availableKeywords
This publication has 13 references indexed in Scilit:
- Increased peripheral blood normal myeloid progenitor cells (CFU-GM) in chronic lymphocytic leukemia: A perspective for autologous peripheral blood stem cell transplantationEuropean Journal of Haematology, 2009
- Fludarabine- and gemcitabine-induced apoptosis: incorporation of analogs into DNA is a critical eventCancer Chemotherapy and Pharmacology, 1995
- Autologous and allogeneic bone marrow transplantation for poor prognosis patients with B-cell chronic lymphocytic leukemiaBlood, 1993
- Long-term follow-up of patients with chronic lymphocytic leukemia treated with fludarabine as a single agentBlood, 1993
- Fludarabine: a new agent with marked cytoreductive activity in untreated chronic lymphocytic leukemia.Journal of Clinical Oncology, 1991
- Fludarabine: a new agent with major activity against chronic lymphocytic leukemiaBlood, 1989
- Chronic Lymphocytic Leukemia: Recommendations for Diagnosis, Staging, and Response CriteriaAnnals of Internal Medicine, 1989
- Prognosis of chronic lymphocytic leukemia: a multivariate regression analysis of 325 untreated patientsBlood, 1987
- A new prognostic classification of chronic lymphocytic leukemia derived from a multivariate survival analysisCancer, 1981
- Comparison of daily versus intermittent chlorambucil and prednisone therapy in the treatment of patients with chronic lymphocytic leukemiaBlood, 1977